Canine interleukin-31 binds directly to OSMR & beta; with higher binding affinity than to IL-31RA

Interleukin-31 (IL-31) is a pro-inflammatory cytokine involved in skin inflammation and tumor progression. The IL-31 signaling cascade is initiated by its binding to two receptors, IL-31 receptor alpha (IL-31RA) and oncostatin M receptor subunit beta (OSMR & beta;). The previous study suggested that human IL-31 (hIL-31) directly interacts with IL-31RA and OSMR & beta;, independently, but the binding ability of hIL-31 to IL-31RA is stronger than to OSMR & beta;. In different to its human ortholog, feline IL-31 (fIL-31) has a higher binding affinity for feline OSMR & beta;. However, the binding pattern of canine IL-31 to its receptors remains to be elucidated. In this study, we purified the recombinant canine IL-31 (rcIL-31) protein and revealed its secondary structure to be mainly composed of alpha-helices. Moreover, in vitro studies show that rcIL-31 has the ability to induce the phosphorylation of signal transducer activator of transcription 3 (STAT3) and STAT5 in DH-82 cells. In the following, the binding efficacies of bioactive rcIL-31 for its individual receptor components have been measured using a flow cytometry assay. The result demonstrates that correctly refolded rcIL-31 binds independently with cIL-31RA and cOSMR & beta; which were expressed on the cell surface. Of note, rcIL-31 has a greater than tenfold higher affinity to OSMR & beta; than to IL-31RA. Additionally, we demonstrated that D1-D4, especially D4 of cOSMR & beta;, is crucial for its binding to cIL-31. Furthermore, this study proved that rcIL-31 has a high binding affinity to the soluble cOSMR & beta; with a KD value of 3.59 x 10(-8) M. The results presented in the current study will have a significant implication in the development of drugs or antibodies against diseases induced by cIL-31 signaling.